Hep C Virus - New Vaccine Candidate Against Hepatitis C - University Of Saskatchewan

New Vaccine Candidate Against Hepatitis C - University Of Saskatchewan
Medical News Today - Researchers at the University of Saskatchewan's Vaccine and Infectious Disease Organization (VIDO) have developed a vaccine candidate for hepatitis C, leading to hope in the fight against a disease for which no vaccines are yet available. VIDO is the

Difficulty In Treating Older Hepatitis C Patients With Combination
Medical News Today - A new study in Japan examining the effects of combination therapy on older patients with hepatitis C found more adverse effects necessitating discontinuation of treatment, lowering of dosages, and lower long-term benefits in this age group. The

Cyclosporine Inhibits Hepatitis C Virus In Vitro
Medical News Today - Liver transplant patients with hepatitis C virus (HCV) achieved significantly better long-term viral response when taking the immunosuppressive agent Cyclosporine along with interferon-ribavirin combination therapy. Cyclosporine also showed efficacy

Medivir: Candidate Drug Designated within the Tibotec Collaboration
Genetic Engineering News - The Hepatitis C Virus (HCV) collaboration with Tibotec Pharmaceuticals Ltd has recently designated a Candidate Drug (CD). The aim of the research collaboration is to identify and develop orally active inhibitors of the HCV protease NS3/4A. The